Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Amortizatization of Intangibles (2019 - 2025)

Historic Amortizatization of Intangibles for Abeona Therapeutics (ABEO) over the last 7 years, with Q3 2025 value amounting to $280000.0.

  • Abeona Therapeutics' Amortizatization of Intangibles rose 1914.89% to $280000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 1406.25%. This contributed to the annual value of $903000.0 for FY2024, which is 76.92% down from last year.
  • According to the latest figures from Q3 2025, Abeona Therapeutics' Amortizatization of Intangibles is $280000.0, which was up 1914.89% from $960000.0 recorded in Q2 2025.
  • In the past 5 years, Abeona Therapeutics' Amortizatization of Intangibles registered a high of $960000.0 during Q2 2025, and its lowest value of -$455000.0 during Q1 2025.
  • Its 5-year average for Amortizatization of Intangibles is $278736.8, with a median of $268000.0 in 2021.
  • Within the past 5 years, the most significant YoY rise in Abeona Therapeutics' Amortizatization of Intangibles was 38484.85% (2025), while the steepest drop was 29527.9% (2025).
  • Quarter analysis of 5 years shows Abeona Therapeutics' Amortizatization of Intangibles stood at $389000.0 in 2021, then dropped by 28.02% to $280000.0 in 2022, then decreased by 17.86% to $230000.0 in 2023, then rose by 3.04% to $237000.0 in 2024, then rose by 18.14% to $280000.0 in 2025.
  • Its Amortizatization of Intangibles was $280000.0 in Q3 2025, compared to $960000.0 in Q2 2025 and -$455000.0 in Q1 2025.